4basebio PLC (4BB.L)
GBp 1125.0
(-0.44%)
GBp 1125.0
(-0.44%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -8.05 Million GBP | -20.82% |
| 2022 | -5.84 Million GBP | -65.58% |
| 2021 | -3.52 Million GBP | -467.04% |
| 2020 | -622 Thousand GBP | -48.1% |
| 2019 | -420 Thousand GBP | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -2.89 Million GBP | 0.0% |
| 2024 Q1 | -2.89 Million GBP | -35.24% |
| 2023 Q4 | -2.14 Million GBP | 2.59% |
| 2023 FY | -7.05 Million GBP | -20.82% |
| 2023 Q2 | -3.28 Million GBP | -74.6% |
| 2023 Q1 | -1.88 Million GBP | 24.54% |
| 2023 Q3 | -2.2 Million GBP | 33.02% |
| 2022 Q2 | -2.31 Million GBP | -70.38% |
| 2022 Q1 | -1.35 Million GBP | 8.43% |
| 2022 FY | -5.84 Million GBP | -65.58% |
| 2022 Q4 | -2.49 Million GBP | -68.8% |
| 2022 Q3 | -1.47 Million GBP | 36.09% |
| 2021 Q1 | -908 Thousand GBP | -116.71% |
| 2021 Q4 | -1.48 Million GBP | -73.23% |
| 2021 Q3 | -855.5 Thousand GBP | 50.49% |
| 2021 FY | -3.52 Million GBP | -467.04% |
| 2021 Q2 | -1.72 Million GBP | -90.31% |
| 2020 FY | -622 Thousand GBP | -48.1% |
| 2020 Q4 | -419 Thousand GBP | -232.54% |
| 2020 Q3 | -126 Thousand GBP | 58.96% |
| 2020 Q2 | -307 Thousand GBP | -65.95% |
| 2020 Q1 | -185 Thousand GBP | 0.0% |
| 2019 FY | -420 Thousand GBP | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|